Department of Pharmacology, Shenyang Medical CollegeShenyangP.R. China.
Shanghai Zhaohui Pharmaceutical Co. Ltd.ShanghaiP.R. China.
Oncol Res. 2022 May 4;29(1):1-10. doi: 10.3727/096504021X16401852341873. Epub 2021 Dec 22.
NeuroD1 is a neuronal differentiation factor that contains a basic helixloophelix (bHLH) motif. Recently, NeuroD1 was found to be associated with tumorigenesis in neuroblastoma (NB) and is known to promote cell proliferation and migration in these cells. Here we found that MYCN regulates the expression of NeuroD1 in NB cells and that the downregulation of MYCN using short hairpin RNAs (shRNA) results in the inhibition of cellular proliferation in NB cells. Moreover, the phenotype induced by MYCN shRNA was rescued by the exogenous expression of NeuroD1. Chromatin immunoprecipitation (ChIP) assay showed that MYCN directly binds to the E-box element in the NeuroD1 promoter region. In addition, our evaluation of two clinical databases showed that there was a positive correlation between the expression of MYCN and NeuroD1 in NB patients, which supports our in vitro data. In conclusion, this study demonstrates that MYCN-regulated NeuroD1 expression is one of the important mechanisms underlying enhanced cellular proliferation induced by the increase in MYCN expression in NB, and our results provide an important therapeutic target for NB in the future.
NeuroD1 是一种神经元分化因子,包含一个碱性螺旋-环-螺旋(bHLH)基序。最近,研究发现 NeuroD1 与神经母细胞瘤(NB)的肿瘤发生有关,并已知它可促进这些细胞的增殖和迁移。在这里,我们发现 MYCN 调节 NB 细胞中 NeuroD1 的表达,使用短发夹 RNA(shRNA)下调 MYCN 会导致 NB 细胞的增殖受到抑制。此外,MYCN shRNA 诱导的表型可通过外源性表达 NeuroD1 得到挽救。染色质免疫沉淀(ChIP)实验表明,MYCN 直接结合 NeuroD1 启动子区域的 E 盒元件。此外,我们对两个临床数据库的评估表明,在 NB 患者中,MYCN 和 NeuroD1 的表达之间存在正相关,这支持了我们的体外数据。总之,这项研究表明,MYCN 调节的 NeuroD1 表达是 MYCN 表达增加导致 NB 中细胞增殖增强的重要机制之一,我们的结果为 NB 的未来提供了一个重要的治疗靶点。